Chemed (NYSE:CHE) Releases FY 2024 Earnings Guidance

Chemed (NYSE:CHE - Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 23.300-23.700 for the period, compared to the consensus estimate of 23.520. The company issued revenue guidance of -. Chemed also updated its FY24 guidance to $23.30-23.70 EPS.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CHE. Oppenheimer lifted their target price on Chemed from $625.00 to $650.00 and gave the company an outperform rating in a research report on Thursday, February 29th. Royal Bank of Canada boosted their price target on Chemed from $604.00 to $712.00 and gave the stock an outperform rating in a research report on Monday, March 4th.

Get Our Latest Report on CHE

Chemed Stock Performance

Shares of Chemed stock traded up $1.44 on Wednesday, hitting $617.95. The stock had a trading volume of 67,370 shares, compared to its average volume of 77,478. The stock has a 50 day moving average of $623.23 and a 200 day moving average of $590.47. Chemed has a twelve month low of $492.84 and a twelve month high of $654.62. The firm has a market capitalization of $9.34 billion, a P/E ratio of 34.47, a PEG ratio of 2.43 and a beta of 0.42.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Tuesday, February 27th. The company reported $6.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.25 by $0.35. Chemed had a return on equity of 32.29% and a net margin of 12.03%. The company had revenue of $585.90 million during the quarter, compared to the consensus estimate of $586.64 million. During the same quarter in the prior year, the firm posted $5.39 earnings per share. The firm's revenue was up 7.2% compared to the same quarter last year. Equities analysts expect that Chemed will post 21.99 earnings per share for the current year.

Chemed Announces Dividend


The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.26%. Chemed's dividend payout ratio (DPR) is presently 8.93%.

Insider Activity

In related news, VP Brian C. Judkins sold 11,158 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the completion of the transaction, the vice president now directly owns 1,422 shares of the company's stock, valued at $917,190. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, VP Brian C. Judkins sold 11,158 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the sale, the vice president now directly owns 1,422 shares in the company, valued at $917,190. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Michael D. Witzeman sold 2,650 shares of the stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $643.14, for a total value of $1,704,321.00. Following the completion of the sale, the chief financial officer now owns 2,882 shares in the company, valued at $1,853,529.48. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,808 shares of company stock valued at $10,184,531. Company insiders own 3.32% of the company's stock.

About Chemed

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Earnings History and Estimates for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ The #1 Crypto for AI (From Weiss Ratings) (Ad)

Should you invest $1,000 in Chemed right now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: